These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25865527)

  • 1. Complications of Stevens-Johnson syndrome beyond the eye and skin.
    Saeed H; Mantagos IS; Chodosh J
    Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up.
    Lee HY; Walsh SA; Creamer D
    Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 5. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N
    Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP
    Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary care in Stevens-Johnson syndrome.
    Shanbhag SS; Chodosh J; Fathy C; Goverman J; Mitchell C; Saeed HN
    Ther Adv Chronic Dis; 2020; 11():2040622319894469. PubMed ID: 32523661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y
    Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular manifestations of Stevens-Johnson syndrome and their management.
    Saeed HN; Chodosh J
    Curr Opin Ophthalmol; 2016 Nov; 27(6):522-529. PubMed ID: 27585215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Apr; 14(2):168-88. PubMed ID: 26882981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Gao TT; Li Y; Liu J; Long Q
    Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):177-181. PubMed ID: 28316191
    [No Abstract]   [Full Text] [Related]  

  • 17. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
    Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
    Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
    Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
    Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
    Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.
    Chang VS; Chodosh J; Papaliodis GN
    Semin Ophthalmol; 2016; 31(1-2):178-87. PubMed ID: 26959145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.